Network Analysis of 20S-Ginsenoside Rg3 Effect on Human Colorectal Adenocarcinoma Cell Line HT-29

Document Type : Original paper


1 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

3 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

4 Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5 Research Institute for Gastroenterology and Liver Diseases, Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Background and objectives: 20S-Ginsenoside Rg3 is a pharmacological active compound of ginseng. Evidences indicate that S20-Rg3 as an anti-cancer factor plays role in prevention and treatment of cancer. In the present study, proteomic data of 20S-ginsenoside Rg3 effect on human colorectal adenocarcinoma cell line HT-29 was analyzed via network analysis to understand more details about the molecular events. Methods: The differentially expressed proteins (DEPs) related to the effect of 20S-ginsenoside Rg3 on human colorectal adenocarcinoma cell line HT-29 were extracted from literature and analyzed via protein-protein interaction (PPI) network. The central nodes of the network were determined based on degree value and betweenness centrality. Results: Eight DEPS plus 100 added first neighbors were included in the PPI network. Five central nodes as hub-bottlenecks including ACTB, GAPDH, TP53, AKT1, and ALB among the added first neighbors and ANXA5 as hub-bottleneck and GSTP1 and PCNA as bottlenecks among the queried DEPs were introduced. Conclusion: PCNA, GSTP1, and ANxA5 as cell protective proteins are the crucial targeted proteins by 20S-ginsenoside Rg3 in the treated cell line HT-29. Up-regulation of GSTP1 and ANXA5 is correspondent to the cell protective property of 20S-ginsenoside Rg3, and down-regulation of PCNA refers to the opposite effect. It seems that cell protective roles of 20S-ginsenoside Rg3 are accompanied with the possible side effects.


Main Subjects

  • Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park Proteomic analysis of the anti-cancer effect of 20 S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem. 2009; 73(4): 811–816.
  • Sun M, Ye Y, Xiao L, Duan X, Zhang Y, Zhang H. Anticancer effects of ginsenoside Rg3. Int J Mol Med. 2017; 39(3): 507–518.
  • Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep. 2012; 5(5): 1295–1298.
  • Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, Lu W, Weng H, Shu Y, Gong W, Wang X, Zhang Y, Shi W, Dong P, Gu J, Liu 20 (S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des Devel Ther. 2015; 9: 3969–3987.
  • Arjmand B, Zamanian Azodi M, Rezaei Tavirani M, Khodadoost M, Rostami Nejad M, Ahmadi N. Tumorigenesis inhibition of carnosol from rosemary: an insight to molecular targeting. Res J Pharmacogn. 2022; 9(1): 103–110.
  • Rostami-Nejad M, Razzaghi M, Esmaeili S, Zali A, Rezaei-Tavirani M, Heidari MH, Rezaei-Tavirani M, Zamanian-Azodi M, Ahmadi Evaluation of anticancer and neuroprotective properties of curcumin: a network analysis. Res J Pharmacogn. 2020; 7(3): 85–92.
  • Guingab-Cagmat J, Cagmat E, Hayes RL, Anagli J. Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery. Front Neurol. 2013; 4: 1–12.
  • Vella D, Marini S, Vitali F, Di Silvestre D, Mauri G, Bellazzi R. MTGO: PPI network analysis via topological and functional module identification. Sci Rep. 2018; 8(1): 1–13.
  • Ghasemi M, Seidkhani H, Tamimi F, Rahgozar M, Masoudi-Nejad A. Centrality measures in biological networks. Curr Bioinform. 2014; 9(4): 426–441.
  • He X, Zhang J. Why do hubs tend to be essential in protein networks? PLoS Genet. 2006; 2(6): 1–9.
  • Dietz KJ, Jacquot JP, Harris G. Hubs and bottlenecks in plant molecular signalling networks. New Phytol. 2010; 188(4): 919–938.
  • Bahia W, Soltani I, Abidi A, Haddad A, Ferchichi S, Menif S, Almawi Identification of genes and miRNA associated with idiopathic recurrent pregnancy loss: an exploratory data mining study. BMC Med Genomics. 2020; 13(1): 1–13.
  • Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res. 2016; 45(1): 362–368.
  • Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringapp: network analysis and visualization of proteomics data. J Proteome Res. 2018; 18(2): 623–632.
  • Leary S, Gaudieri S, Parker MD, Chopra A, James I, Pakala S, Alves E, John M, Lindsey BB, Keeley AJ, Rowland-Jones SL, Swanson MS, Ostrov DA, Bubenik JL, Das SR, Sidney J, Sette A, COVID-19 genomics UK (COG-UK) consortium, de Silva TI, Phillips E, Mallal S. Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. Pathog Immun. 2021; 6(2): 1–23.
  • Gu Y, Tang S, Wang Z, Cai L, Lian H, Shen Y, Zhou Y. A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers. Bioengineered. 2021; 12(1): 6166–6185.
  • Nicholls C, Li H, Liu JP. GAPDH: a common enzyme with uncommon functions. Clin Exp Pharmacol Physiol. 2012; 39(8): 674–679.
  • Guo C, Liu S, Sun MZ. Novel insight into the role of GAPDH playing in tumor. Clin Transl Oncol. 2013; 15(3): 167–172.
  • Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe The role of TP53 in cervical carcinogenesis. Hum Mutat. 2003; 21(3): 307–312.
  • Liu H, Radisky DC, Nelson CM, Zhang H, Fata JE, Roth RA, Bissell Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci USA. 2006; 103(11): 4134–4139.
  • Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, Xu J, Ni Q, Luo G, Yu Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surgic Oncol. 2017; 24(2): 561–568.
  • Ibarrola‐Villava M, Martin‐Gonzalez M, Lazaro P, Pizarro A, Lluch A, Ribas G. Role of glutathione S‐transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br J Dermatol. 2012; 166(6): 1176–1183.
  • Aynacioglu AS, Nacak M, Filiz A, Ekinci E, Roots I. Protective role of glutathione S‐transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma. Br J Clin Pharmacol. 2004; 57(2): 213–217.
  • González-Magaña A, Blanco FJ. Human PCNA structure, function and interactions. Biomolecules. 2020; 10(4): 1–19.
  • Bhardwaj V, Purohit R. Computational investigation on effect of mutations in PCNA resulting in structural perturbations and inhibition of mismatch repair pathway. J Biomol Struct Dyn. 2020; 38(7): 1963–1974.
  • de Jong R, Pluijmert NJ, de Vries MR, Pettersson K, Atsma DE, Jukema JW, Quax Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. Sci Rep. 2018; 8(1): 1–10.
  • Zhang L, Qin Z, Li R, Wang S, Wang W, Tang M, Zhang The role of ANXA5 in DBP-induced oxidative stress through ERK/Nrf2 pathway. Environ Toxicol Pharmacol. 2019; 72: 1–9.